Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clopidogrel in Advanced Pancreatic Cancer
NCT02404363Phase 3Terminated
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clopidogrel in Pancreatic ductal adenocarcinoma (PDAC), sponsored by Assistance publique - Hôpitaux de Paris. Started Jan 2016; status: terminated.
02
Drugs
clopidogrel
03
Conditions
Pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT02404363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02404363.